← Leaderboards
Huidong Shi
University Of Missouri-Columbia
$4,464,396
Attributed
$7,243,307
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,243,307 · 8
By mechanism
R01$4,872,490 · 2
R33$942,026 · 1
R21$727,292 · 2
R41$399,999 · 1
R03$301,500 · 2
Top collaborators
- Kun Zhang5 shared
- Gang Zhou5 shared
- Jeong-Hyeon Choi2 shared
- Stephan Wade Morris1 shared
- Thomas Roy Webb1 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Tim H.-M. Huang$22,527,443
- Eric L Greidinger$1,316,449
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsEpigenetic ProcessEpigenomicsTumorTechnologySamplingDna MethylationPhenotypePlayCellsMethylationGenesGenomeFutureBasePatternGene ExpressionBisulfiteBiologicalBioinformaticsAberrant Dna MethylationNovel StrategiesLaboratoriesCpg Islands
Grant awards (24)
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy$522,742
R01 · FY2025 · CA
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy$496,606
R01 · FY2024 · CA
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy$512,286
R01 · FY2023 · CA
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy$512,286
R01 · FY2022 · CA
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy$528,183
R01 · FY2021 · CA
Efficacy of a novel small-molecule splicing modulator in chronic lymphocytic leukemia (CLL)$399,999
R41 · FY2020 · CA
Identification of clonal DNA methylation and chromatin accessibility$76,000
R03 · FY2018 · CA · contact PI
Identification of clonal DNA methylation and chromatin accessibility$76,000
R03 · FY2017 · CA · contact PI
Epigenetic regulation of T-cell dysfunction in chronic lymphocytic leukemia$165,209
R21 · FY2015 · CA · contact PI
Epigenetic regulation of T-cell dysfunction in chronic lymphocytic leukemia$196,947
R21 · FY2014 · CA · contact PI
Genome-scale anaylsis of DNA methylation in CpG Islands with bisulfite sequencing$506,670
R01 · FY2011 · DA
Application of 454 Sequencing to Cancer Epigenomics$305,392
R33 · FY2011 · CA · contact PI
Genome-scale anaylsis of DNA methylation in CpG Islands with bisulfite sequencing$538,771
R01 · FY2010 · DA
Application of 454 Sequencing to Cancer Epigenomics$315,300
R33 · FY2010 · CA · contact PI
Genome-scale anaylsis of DNA methylation in CpG Islands with bisulfite sequencing$544,214
R01 · FY2009 · DA
Application of 454 Sequencing to Cancer Epigenomics$321,334
R33 · FY2009 · CA · contact PI
Genome-scale anaylsis of DNA methylation in CpG Islands with bisulfite sequencing$152,893
R01 · FY2009 · DA
Genome-scale anaylsis of DNA methylation in CpG Islands with bisulfite sequencing$557,839
R01 · FY2008 · DA
Integrated Genetic and Epigenetic Biomarkers for Molecular Epidemiology$43,599
R03 · FY2008 · CA · contact PI
Integrated Genetic and Epigenetic Biomarkers for Molecular Epidemiology$31,151
R03 · FY2008 · CA · contact PI
Epigenetic Targeting in Non-Hodgkin's Lymphoma$151,532
R21 · FY2007 · CA · contact PI
Integrated Genetic and Epigenetic Biomarkers for Molecular Epidemiology$74,750
R03 · FY2007 · CA · contact PI
Epigenetic Targeting in Non-Hodgkin's Lymphoma$11,779
R21 · FY2007 · CA · contact PI
Epigenetic Targeting in Non-Hodgkin's Lymphoma$201,825
R21 · FY2006 · CA · contact PI